{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:14:36Z","timestamp":1778314476340,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1038\/s41423-020-00525-3","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T07:01:56Z","timestamp":1599721316000},"page":"992-1004","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["The inhibitor effect of RKIP on inflammasome activation and inflammasome-dependent diseases"],"prefix":"10.1038","volume":"18","author":[{"given":"Qiang","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia\u2019nan","family":"Shou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,8]]},"reference":[{"key":"525_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1600-065X.2011.01046.x","volume":"243","author":"O Gross","year":"2011","unstructured":"Gross, O., Thomas, C. J., Guarda, G. & Tschopp, J. The inflammasome: an integrated view. Immunol. Rev. 243, 136\u2013151, https:\/\/doi.org\/10.1111\/j.1600-065X.2011.01046.x (2011).","journal-title":"Immunol. Rev."},{"key":"525_CR2","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ni.2550","volume":"14","author":"T Misawa","year":"2013","unstructured":"Misawa, T. et al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat. Immunol. 14, 454, https:\/\/doi.org\/10.1038\/ni.2550 (2013).","journal-title":"Nat. Immunol."},{"key":"525_CR3","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm.3893","volume":"21","author":"HT Guo","year":"2015","unstructured":"Guo, H. T., Callaway, J. B. & Ting, J. P. Y. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat. Med. 21, 677\u2013687, https:\/\/doi.org\/10.1038\/nm.3893 (2015).","journal-title":"Nat. Med."},{"key":"525_CR4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1146\/annurev-immunol-031210-101405","volume":"29","author":"BK Davis","year":"2011","unstructured":"Davis, B. K., Wen, H. T. & Ting, J. P. Y. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 29, 707\u2013735, https:\/\/doi.org\/10.1146\/annurev-immunol-031210-101405 (2011).","journal-title":"Annu. Rev. Immunol."},{"key":"525_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature10558","volume":"479","author":"N Kayagaki","year":"2011","unstructured":"Kayagaki, N. et al. Non-canonical inflammasome activation targets caspase-11. Nature 479, 117\u2013U146, https:\/\/doi.org\/10.1038\/nature10558 (2011).","journal-title":"Nature"},{"key":"525_CR6","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1126\/science.1240248","volume":"341","author":"N Kayagaki","year":"2013","unstructured":"Kayagaki, N. et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341, 1246\u20131249, https:\/\/doi.org\/10.1126\/science.1240248 (2013).","journal-title":"Science"},{"key":"525_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1615\/CritRevImmunol.v30.i5.50","volume":"30","author":"S Khare","year":"2010","unstructured":"Khare, S., Luc, N., Dorfleutner, A. & Stehlik, C. Inflammasomes and their activation. Crit. Rev. Immunol. 30, 463\u2013487, https:\/\/doi.org\/10.1615\/CritRevImmunol.v30.i5.50 (2010).","journal-title":"Crit. Rev. Immunol."},{"key":"525_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/ni.1859","volume":"11","author":"T Fernandes-Alnemri","year":"2010","unstructured":"Fernandes-Alnemri, T. et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat. Immunol. 11, 385\u2013394, https:\/\/doi.org\/10.1038\/ni.1859 (2010).","journal-title":"Nat. Immunol."},{"key":"525_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.it.2011.05.004","volume":"32","author":"D De Nardo","year":"2011","unstructured":"De Nardo, D. & Latz, E. NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol. 32, 373\u2013379 (2011).","journal-title":"Trends Immunol."},{"key":"525_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","volume":"160","author":"YQ Yan","year":"2015","unstructured":"Yan, Y. Q. et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell 160, 62\u201373, https:\/\/doi.org\/10.1016\/j.cell.2014.11.047 (2015).","journal-title":"Cell"},{"key":"525_CR11","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357\u2013U1357 (2010).","journal-title":"Nature"},{"key":"525_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237\u2013241, https:\/\/doi.org\/10.1038\/nature04516 (2006).","journal-title":"Nature"},{"key":"525_CR13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka, M. T. et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 493, 674\u2013678, https:\/\/doi.org\/10.1038\/nature11729 (2013).","journal-title":"Nature"},{"key":"525_CR14","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/ni.1935","volume":"11","author":"SL Masters","year":"2010","unstructured":"Masters, S. L. et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1 beta in type 2 diabetes. Nat. Immunol. 11, 897\u2013U1501, https:\/\/doi.org\/10.1038\/ni.1935 (2010).","journal-title":"Nat. Immunol."},{"key":"525_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll, R. C. et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 21, 248\u2013255, https:\/\/doi.org\/10.1038\/nm.3806 (2015).","journal-title":"Nat. Med."},{"key":"525_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm, Y. H. et al. The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat. Med. 21, 263\u2013269, https:\/\/doi.org\/10.1038\/nm.3804 (2015).","journal-title":"Nat. Med."},{"key":"525_CR17","doi-asserted-by":"publisher","first-page":"12504","DOI":"10.1038\/ncomms12504","volume":"7","author":"MJD Daniels","year":"2016","unstructured":"Daniels, M. J. D. et al. Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer\u2019s disease in rodent models. Nat. Commun. 7, 12504(2016).","journal-title":"Nat. Commun"},{"key":"525_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/0167-4838(84)90221-8","volume":"790","author":"I Bernier","year":"1984","unstructured":"Bernier, I. & Jolles, P. Purification and characterization of a Basic 23 Kda cytosolic protein from bovine brain. Biochim. Biophys. Acta 790, 174\u2013181, https:\/\/doi.org\/10.1016\/0167-4838(84)90221-8 (1984).","journal-title":"Biochim. Biophys. Acta"},{"key":"525_CR19","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1006\/jmbi.2001.4784","volume":"310","author":"L Serre","year":"2001","unstructured":"Serre, L. et al. Crystal structures of YBHB and YBCL from Escherichia coli, two bacterial homologues to a Raf kinase inhibitor protein. J. Mol. Biol. 310, 617\u2013634, https:\/\/doi.org\/10.1006\/jmbi.2001.4784 (2001).","journal-title":"J. Mol. Biol."},{"key":"525_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/43686","volume":"401","author":"K Yeung","year":"1999","unstructured":"Yeung, K. et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401, 173\u2013177 (1999).","journal-title":"Nature"},{"key":"525_CR21","doi-asserted-by":"publisher","first-page":"24931","DOI":"10.1074\/jbc.M413929200","volume":"280","author":"N Trakul","year":"2005","unstructured":"Trakul, N., Menard, R. E., Schade, G. R., Qian, Z. H. & Rosner, M. R. Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation. J. Biol. Chem. 280, 24931\u201324940, https:\/\/doi.org\/10.1074\/jbc.M413929200 (2005).","journal-title":"J. Biol. Chem."},{"key":"525_CR22","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/nature02158","volume":"426","author":"K Lorenz","year":"2003","unstructured":"Lorenz, K., Lohse, M. J. & Quitterer, U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 426, 574\u2013579, https:\/\/doi.org\/10.1038\/nature02158 (2003).","journal-title":"Nature"},{"key":"525_CR23","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1158\/0008-5472.CAN-10-3102","volume":"71","author":"F Al-Mulla","year":"2011","unstructured":"Al-Mulla, F. et al. Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3 beta. Cancer Res. 71, 1334\u20131343, https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-3102 (2011).","journal-title":"Cancer Res."},{"key":"525_CR24","doi-asserted-by":"publisher","first-page":"7207","DOI":"10.1128\/Mcb.21.21.7207-7217.2001","volume":"21","author":"KC Yeung","year":"2001","unstructured":"Yeung, K. C. et al. Raf kinase inhibitor protein interacts with NF-kappa B-inducing kinase and TAK1 and inhibits NF-kappa 13 activation. Mol. Cell. Biol. 21, 7207\u20137217, https:\/\/doi.org\/10.1128\/Mcb.21.21.7207-7217.2001 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"525_CR25","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1517\/14728222.12.10.1275","volume":"12","author":"LC Zeng","year":"2008","unstructured":"Zeng, L. C., Imamoto, A. & Rosner, M. R. Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. Expert Opin. Ther. Target 12, 1275\u20131287, https:\/\/doi.org\/10.1517\/14728222.12.10.1275 (2008).","journal-title":"Expert Opin. Ther. Target"},{"key":"525_CR26","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/jcp.24335","volume":"228","author":"F Al-Mulla","year":"2013","unstructured":"Al-Mulla, F., Bitar, M. S., Taqi, Z. & Yeung, K. C. RKIP: much more than Raf kinase inhibitory protein. J. Cell Physiol. 228, 1688\u20131702, https:\/\/doi.org\/10.1002\/jcp.24335 (2013).","journal-title":"J. Cell Physiol."},{"key":"525_CR27","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1136\/gutjnl-2015-310096","volume":"66","author":"WL Lin","year":"2017","unstructured":"Lin, W. L. et al. Raf kinase inhibitor protein mediates intestinal epithelial cell apoptosis and promotes IBDs in humans and mice. Gut 66, 597\u2013610, https:\/\/doi.org\/10.1136\/gutjnl-2015-310096 (2017).","journal-title":"Gut"},{"key":"525_CR28","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.15252\/embj.201694060","volume":"35","author":"M Gu","year":"2016","unstructured":"Gu, M. et al. RKIP and TBK1 form a positive feedback loop to promote type I interferon production in innate immunity. EMBO J. 35, 2553\u20132565, https:\/\/doi.org\/10.15252\/embj.201694060 (2016).","journal-title":"EMBO J."},{"key":"525_CR29","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.4049\/jimmunol.1601672","volume":"198","author":"R Lai","year":"2017","unstructured":"Lai, R. et al. Raf kinase inhibitor protein preferentially promotes TLR3-triggered signaling and inflammation. J. Immunol. 198, 4086\u20134095, https:\/\/doi.org\/10.4049\/jimmunol.1601672 (2017).","journal-title":"J. Immunol."},{"key":"525_CR30","doi-asserted-by":"publisher","first-page":"E9859","DOI":"10.1073\/pnas.1805474115","volume":"115","author":"WL Lin","year":"2018","unstructured":"Lin, W. L. et al. Raf kinase inhibitor protein negatively regulates FceRI-mediated mast cell activation and allergic response. Proc. Natl Acad. Sci. USA 115, E9859\u2013E9868, https:\/\/doi.org\/10.1073\/pnas.1805474115 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"525_CR31","doi-asserted-by":"publisher","first-page":"e44951","DOI":"10.15252\/embr.201744951","volume":"19","author":"WL Lin","year":"2018","unstructured":"Lin, W. L. et al. RKIP mediates autoimmune inflammation by positively regulating IL-17R signaling. EMBO Rep. 19, e44951 (2018).","journal-title":"EMBO Rep"},{"key":"525_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imr.12534","volume":"277","author":"SM Man","year":"2017","unstructured":"Man, S. M., Karki, R. & Kanneganti, T. D. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol. Rev. 277, 61\u201375 (2017).","journal-title":"Immunol. Rev."},{"key":"525_CR33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3324\/haematol.2018.209650","volume":"105","author":"V Caraffini","year":"2020","unstructured":"Caraffini, V. et al. Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation an aggravates RAS-driven myeloid leukemogenesis. Haematologica 105, 375\u2013386 (2020).","journal-title":"Haematologica"},{"key":"525_CR34","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1002\/art.38747","volume":"66","author":"LL Reber","year":"2014","unstructured":"Reber, L. L. et al. Contribution of mast cell-derived interleukin-1 beta to uric acid crystal-induced acute arthritis in mice. Arthritis Rheumatol. 66, 2881\u20132891 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"525_CR35","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","volume":"9","author":"HB He","year":"2018","unstructured":"He, H. B. et al. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat. Commun. 9, 2550 (2018).","journal-title":"Nat. Commun"},{"key":"525_CR36","first-page":"1892","volume":"49","author":"Y Huang","year":"2019","unstructured":"Huang, Y. & Rong, R. Tranilast directly targets NLRP3 to treat inflammasome-driven diseases. Eur. J. Immunol. 49, 1892\u20131892 (2019).","journal-title":"Eur. J. Immunol."},{"key":"525_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.2279","volume":"17","author":"B Vandanmagsar","year":"2011","unstructured":"Vandanmagsar, B. et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179\u2013U214, https:\/\/doi.org\/10.1038\/nm.2279 (2011).","journal-title":"Nat. Med."},{"key":"525_CR38","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nature10759","volume":"481","author":"T Strowig","year":"2012","unstructured":"Strowig, T., Henao-Mejia, J., Elinav, E. & Flavell, R. Inflammasomes in health and disease. Nature 481, 278\u2013286, https:\/\/doi.org\/10.1038\/nature10759 (2012).","journal-title":"Nature"},{"key":"525_CR39","doi-asserted-by":"publisher","unstructured":"Jin, J. et al. LRRFIP2 negatively regulates NLRP3 inflammasome activation in macrophages by promoting Flightless-I-mediated caspase-1 inhibition. Nat. Commun. 4, 2075. https:\/\/doi.org\/10.1038\/Ncomms3075 (2013).","DOI":"10.1038\/Ncomms3075"},{"key":"525_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nature13322","volume":"512","author":"L Vande Walle","year":"2014","unstructured":"Vande Walle, L. et al. Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis. Nature 512, 69\u201373, https:\/\/doi.org\/10.1038\/nature13322 (2014).","journal-title":"Nature"},{"key":"525_CR41","doi-asserted-by":"publisher","unstructured":"Yang, C. S. et al. Small heterodimer partner interacts with NLRP3 and negatively regulates activation of the NLRP3 inflammasome. Nature Commun. 6, 6115. https:\/\/doi.org\/10.1038\/Ncomms7115 (2015).","DOI":"10.1038\/Ncomms7115"},{"key":"525_CR42","doi-asserted-by":"publisher","unstructured":"Huai, W. W. et al. Aryl hydrocarbon receptor negatively regulates NLRP3 inflammasome activity by inhibiting NLRP3 transcription. Nature Commun. 5, 4738. https:\/\/doi.org\/10.1038\/Ncomms5738 (2014).","DOI":"10.1038\/Ncomms5738"},{"key":"525_CR43","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1084\/jem.20161452","volume":"214","author":"G Lorden","year":"2017","unstructured":"Lorden, G. et al. Lipin-2 regulates NLRP3 inflammasome by affecting P2X(7) receptor activation. J. Exp. Med. 214, 511\u2013528, https:\/\/doi.org\/10.1084\/jem.20161452 (2017).","journal-title":"J. Exp. Med."},{"key":"525_CR44","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.4049\/jimmunol.1401989","volume":"194","author":"KR Mao","year":"2015","unstructured":"Mao, K. R. et al. beta-arrestin1 is critical for the full activation of NLRP3 and NLRC4 inflammasomes. J. Immunol. 194, 1867\u20131873, https:\/\/doi.org\/10.4049\/jimmunol.1401989 (2015).","journal-title":"J. Immunol."},{"key":"525_CR45","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nature02166","volume":"426","author":"JS Andersen","year":"2003","unstructured":"Andersen, J. S. et al. Proteomic characterization of the human centrosome by protein correlation profiling. Nature 426, 570\u2013574, https:\/\/doi.org\/10.1038\/nature02166 (2003).","journal-title":"Nature"}],"container-title":["Cellular & Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00525-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00525-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00525-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T23:21:32Z","timestamp":1631056892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00525-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,8]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["525"],"URL":"https:\/\/doi.org\/10.1038\/s41423-020-00525-3","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,8]]},"assertion":[{"value":"24 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}